Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01481571 · ClinicalTrials.gov registry record · NA
Performance Study of New Media for Vitrification of Human Oocytes
A NA study, sponsored by Vitrolife.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01481571: Completed NA study, sponsored by Vitrolife.
NCT01481571 is a NA study that has completed, run by Vitrolife. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01481571, a NA study, has completed, sponsored by Vitrolife.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate safety and performance of Vitrolife´s new oocyte vitrification/warming media and the vitrification device Rapid-i™, when using vitrification as a cryopreservation method for human oocytes.
Primary Outcome
Embryo development, as number of good quality blastocysts, after oocyte vitrification and warming.
Interventions
- DEVICE Vitrification medium oocyte, warming medium oocyte and Rapid-i
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT01481571 record still lists
NCT01481571 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Vitrification medium oocyte, warming medium oocyte and Rapid-i is the first listed.
NCT01481571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01481571 about?
NCT01481571 is a clinical study titled "Performance Study of New Media for Vitrification of Human Oocytes". The purpose of this study is to evaluate safety and performance of Vitrolife´s new oocyte vitrification/warming media and the vitrification device Rapid-i™, when using vitrification as a cryopreservation method for human oocytes.
What is the current status of trial NCT01481571?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2012-01. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01481571?
The interventions under investigation include: Vitrification medium oocyte, warming medium oocyte and Rapid-i (DEVICE).
Who is sponsoring clinical trial NCT01481571?
This trial is sponsored by Vitrolife, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01481571's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia